These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 34236075)
1. Recent advancements in the exploitation of the gut microbiome in the diagnosis and treatment of colorectal cancer. Stott KJ; Phillips B; Parry L; May S Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34236075 [TBL] [Abstract][Full Text] [Related]
2. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis? Hatton G; Shawcross DL Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):1-2. PubMed ID: 30791837 [No Abstract] [Full Text] [Related]
3. Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer. Lin C; Cai X; Zhang J; Wang W; Sheng Q; Hua H; Zhou X Digestion; 2019; 100(1):72-78. PubMed ID: 30332668 [TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes. Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239 [TBL] [Abstract][Full Text] [Related]
5. Microbial Interactions and Interventions in Colorectal Cancer. Van Raay T; Allen-Vercoe E Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625 [TBL] [Abstract][Full Text] [Related]
6. Intervention on gut microbiota may change the strategy for management of colorectal cancer. Taghinezhad-S S; Mohseni AH; Fu X J Gastroenterol Hepatol; 2021 Jun; 36(6):1508-1517. PubMed ID: 33295040 [TBL] [Abstract][Full Text] [Related]
7. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. Suk KT; Kim DJ Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767 [TBL] [Abstract][Full Text] [Related]
8. Implications of Gut Microbiota in Complex Human Diseases. Yu D; Meng X; de Vos WM; Wu H; Fang X; Maiti AK Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884466 [TBL] [Abstract][Full Text] [Related]
9. Targeting Dysbiosis for the Treatment of Liver Disease. Anand G; Zarrinpar A; Loomba R Semin Liver Dis; 2016 Feb; 36(1):37-47. PubMed ID: 26870931 [TBL] [Abstract][Full Text] [Related]
10. Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa. Lawrence GW; Begley M; Cotter PD; Guinane CM Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019270 [TBL] [Abstract][Full Text] [Related]
11. Predictive values of colon microbiota in the treatment response to colorectal cancer. Galan-Ros J; Ramos-Arenas V; Conesa-Zamora P Pharmacogenomics; 2020 Sep; 21(14):1045-1059. PubMed ID: 32896201 [TBL] [Abstract][Full Text] [Related]
12. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer. Yuan L; Zhang S; Li H; Yang F; Mushtaq N; Ullah S; Shi Y; An C; Xu J Biomed Pharmacother; 2018 Dec; 108():184-193. PubMed ID: 30219675 [TBL] [Abstract][Full Text] [Related]
13. Study Insights into Gastrointestinal Cancer through the Gut Microbiota. Kong F; Cai Y Biomed Res Int; 2019; 2019():8721503. PubMed ID: 31341907 [TBL] [Abstract][Full Text] [Related]
14. High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites. Yang J; Wei H; Zhou Y; Szeto CH; Li C; Lin Y; Coker OO; Lau HCH; Chan AWH; Sung JJY; Yu J Gastroenterology; 2022 Jan; 162(1):135-149.e2. PubMed ID: 34461052 [TBL] [Abstract][Full Text] [Related]
15. Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure. Jia Q; Li H; Zhou H; Zhang X; Zhang A; Xie Y; Li Y; Lv S; Zhang J Cardiovasc Ther; 2019; 2019():5164298. PubMed ID: 31819762 [TBL] [Abstract][Full Text] [Related]
16. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. Fong W; Li Q; Yu J Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151 [TBL] [Abstract][Full Text] [Related]
17. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?]. Bruneau A; Baylatry MT; Joly AC; Sokol H Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301 [TBL] [Abstract][Full Text] [Related]
18. Microbe-based management for colorectal cancer. Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639 [TBL] [Abstract][Full Text] [Related]
19. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease. Babickova J; Gardlik R World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290 [TBL] [Abstract][Full Text] [Related]
20. Strategies for the treatment of colorectal cancer caused by gut microbiota. de Souza JB; Brelaz-de-Castro MCA; Cavalcanti IMF Life Sci; 2022 Feb; 290():120202. PubMed ID: 34896161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]